Armand Butera

The institute will assemble and support a diverse, multidisciplinary team of scientists and researchers to lead the charge breakthroughs in airway science.

Preconception paternal smoking was also not associated with birth weight or paternal BMI.

Despite the assumption of vaccine hesitancy among Black people in the US, the present study found rapid reductions in COVID-19 vaccine hesitancy among Black individuals in the US.

The therapeutic met all secondary endpoints measured at 18 months in patients with hATTR amyloidosis with polyneuropathy, which included statistically significant improvements in neuropathy, and quality of life.

After its approval by the FDA, no new safety findings were reported on weekly dosing of the biologic.

Patients with asthma were at increased risk of hospitalization and ICU admission or death, prompting investigators to suggest these patients be considered a priority group for booster COVID-19 vaccines.

Dr. Ivy speaks on promising new therapies and training for sickle cell management during the first blood shortage in the United States in 10 years.

Investigators note that validation of these biomarkers would require multi-center and independent validation of the current findings.

There are currently no approved systemic treatments for prurigo nodularis, but patients treated with dupilumab experienced significantly greater improvements in measures of overall health-related quality of life, skin pain, and symptoms of anxiety and depression.

Investigators observed that many patients with psoriasis are not actively seeing a primary care physician and would welcome management of their cardiovascular risk factors.

Data from a recent Chinese cohort study supported the development of dietary guidelines specific to obstructive sleep apnea.

Patients with severe eosinophilic asthma who stopped treatment also experienced reduced asthma control and shorter times for clinically significant exacerbations.

Dr. Siddharthan speaks of high COPD rates in low- and middle-income countries with increased environmental exposures and a lack of diagnostic tools.

Swedish investigators noted differences in the prevalence of atopic dermatitis among the 2 sexes, and considered it important data for clinicians that treat patients with the disease.

Investigators believe drugs like etanercept and ustekinumab could reduce the risk of psoriatic arthritis in patients with moderate-to-severe chronic plaque psoriasis.

Investigators in China observed a substantial decrease in the number of severe cases after the arrival of the EV-A71 vaccine.

The newest venture from Mount Sinai is intended to build a pipeline of physician-scientists.

The decision was supported by 5 clinical trials that resulted in significant improvements in skin clearance, extent of disease, and severity.

Upadacitinib is now indicated for children 12 years and older, and can be used as a monotherapy or with topical corticosteroids.

Trials of CBP-201 for asthma and chronic rhinosinusitis with nasal polyps are ongoing, and early data from the atopic dermatitis trial were promising.

The discriminative accuracy of the 3 instruments were evaluated in low- and middle-income settings in Nepal, Peru, and Uganda, with further research needed to determine whether implementation is associated with improved clinical outcomes.

Dr. Talbot speaks to the variety of different strains of influenza, and how research into different flu vaccines could be informed by advancements made in the management of shingles and COVID-19.

Investigators concluded that long-term data are needed regarding surgery, but confirmed it to be more efficacious than medical therapy alone.

Deaths attributed to pneumonia, influenza, and COVID-19 were above the epidemic threshold, per the latest CDC report.

The skin disease was also linked to higher levels of glucosyl cholesterol which was strongly associated with disease severity.

The results suggested that the microbial changes were secondary in the pathogenesis of the skin disease.

Dr. Silverberg speaks of the recent FDA approval of the biologic for patients with moderate-to-severe atopic dermatitis.

Additionally, no increase in incidences of stroke or pulmonary embolism were seen 14 days after the 2 vaccine doses.

Rebecca Rosenberger discusses allergic and non-allergic triggers, and how patients with food allergies can avoid allergic reactions through the winter season.

Previous studies suggested that the disorder is caused by immunoglobulin G (IgG) antibodies against the NC16A domain of collagen XVII.